Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-24 @ 11:36 PM
NCT ID:
NCT02198456
Eligibility Criteria:
Inclusion Criteria:
* age \>17
* pulmonary arterial hypertension WHO group I who are going to start a therapy with prostanoid
* written informed consent
* Prostanoid naive
* no change of the pulmonary arterial hypertension therapy within 3 weeks of inclusion into the study
Exclusion Criteria:
* pregnancy and lactation period
* Women of childbearing potential who do not use an effective and secure method for birth control
* severe chronic kidney insufficiency (glomerular filtration rate \<30), which will remain for more than 3 months
* liver insufficiency Child C
* life expectancy shorter than the course of the study (for example because of a malignant disease)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02198456
Study Brief:
Protocol Section:
NCT02198456